Wells Fargo’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-15,652
| Closed | -$92K | – | 6903 |
|
|
2019
Q1 | $92K | Sell |
15,652
-64,347
| -80% | -$219K | ﹤0.01% | 5162 |
|
|
2018
Q4 | $104K | Sell |
79,999
-64,116
| -44% | -$111K | ﹤0.01% | 5263 |
|
|
2018
Q3 | $497K | Sell |
144,115
-2,114
| -1% | -$7.94K | ﹤0.01% | 4445 |
|
|
2018
Q2 | $666K | Sell |
146,229
-3,575
| -2% | -$14.2K | ﹤0.01% | 4255 |
|
|
2018
Q1 | $495K | Buy |
149,804
+5,837
| +4% | +$20.7K | ﹤0.01% | 4394 |
|
|
2017
Q4 | $562K | Sell |
143,967
-30,924
| -18% | -$168K | ﹤0.01% | 4311 |
|
|
2017
Q3 | $1.81M | Sell |
174,891
-43,809
| -20% | -$431K | ﹤0.01% | 3393 |
|
|
2017
Q2 | $2.13M | Buy |
218,700
+69,813
| +47% | +$490K | ﹤0.01% | 3172 |
|
|
2017
Q1 | $1.01M | Buy |
148,887
+47,266
| +47% | +$273K | ﹤0.01% | 3743 |
|
|
2016
Q4 | $559K | Buy |
101,621
+97,421
| +2,320% | +$688K | ﹤0.01% | 4134 |
|
|
2016
Q3 | $32K | Sell |
4,200
-8
| -0.2% | -$58 | ﹤0.01% | 5474 |
|
|
2016
Q2 | $34K | Sell |
4,208
-1,104
| -21% | -$13.8K | ﹤0.01% | 5336 |
|
|
2016
Q1 | $69K | Buy |
5,312
+87
| +2% | +$1K | ﹤0.01% | 5087 |
|
|
2015
Q4 | $105K | Buy |
5,225
+514
| +11% | +$8.86K | ﹤0.01% | 4884 |
|
|
2015
Q3 | $57K | Sell |
4,711
-606
| -11% | -$11.4K | ﹤0.01% | 5221 |
|
|
2015
Q2 | $109K | Buy |
5,317
+4,826
| +983% | +$114K | ﹤0.01% | 5014 |
|
|
2015
Q1 | $11K | Buy |
491
+108
| +28% | +$2.82K | ﹤0.01% | 5615 |
|
|
2014
Q4 | $12K | Buy |
+383
| New | +$10.6K | ﹤0.01% | 5576 |
|
Wells Fargo's IMDZ Position: Q2 2019 in Review
Wells Fargo sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 15,652 shares — an estimated $92K sold.
Wells Fargo first reported a position in IMDZ in Q4 2014 and held it in 18 quarters. The position peaked at $2.13M in Q2 2017. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Wells Fargo reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Wells Fargo sold 15,652 Immune Design Corp. shares in Q2 2019, an estimated $92K.
- Wells Fargo first reported a position in Immune Design Corp. in Q4 2014 and held it in 18 quarters.
- Wells Fargo's Immune Design Corp. position peaked at $2.13M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Wells Fargo's 13F filing for Q2 2019, filed 6 Aug 2019.